Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR201203000369163Not yet recruiting
Open-label trial of tranexamic acid and ornipressin in Fibromyoma (LM), sponsored by Aga Khan University. Primary endpoint: Blood loss in each group. Planned start May 2012; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR201203000369163.